Haploinsufficiency of c-met in cd44-/- mice identifies a collaboration of CD44 and c-met in vivo

被引:41
|
作者
Matzke, Alexandra
Sargsyan, Vardanush
Holtmann, Bettina
Aramuni, Gayane
Asan, Esther
Sendtner, Michael
Pace, Giuseppina
Howells, Norma
Zhang, Weiqi
Ponta, Helmut
Orian-Rousseau, Veronique
机构
[1] Forschungszentrum Karlsruhe, Inst Toxicol Genet, D-76021 Karlsruhe, Germany
[2] Univ Gottingen, Dept Neurophysiol, D-37073 Gottingen, Germany
[3] Univ Gottingen, DFG Res Ctr Mol Physiol Brain, D-37073 Gottingen, Germany
[4] Univ Wurzburg, Inst Clin Neurobiol, D-97080 Wurzburg, Germany
[5] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany
关键词
D O I
10.1128/MCB.01355-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence has shown that the activation of receptor tyrosine kinases is not only dependent on binding of their ligands but in addition requires adhesion molecules as coreceptors. We have identified CD44v6 as a coreceptor for c-Met in several tumor and primary cells. The CD44v6 ectodomain is required for c-Met activation, whereas the cytoplasmic tail recruits ERM proteins and the cytoskeleton into a signalosome complex. Here we demonstrate that c-Met (and hepatocyte growth factor and Gab1) is haploinsufficient in a cd44(-/-) background, as the cd44(-/-); met(-/-) (and cd44(-/-); hgf(+/-) and cd44(-/-); gab1(+/-)) mice die at birth. They have impaired synaptic transmission in the respiratory rhythm-generating network and alterations in the phrenic nerve. These results are the first genetic data showing that CD44 and c-Met collaborate in vivo and that they are involved in synaptogenesis and axon myelination in the central and peripheral nervous systems.
引用
收藏
页码:8797 / 8806
页数:10
相关论文
共 50 条
  • [31] c-Met and miRs in Cancer
    Giglio, Simona
    Vecchione, Andrea
    BIOMEDICINES, 2015, 3 (01): : 32 - 44
  • [32] Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
    Zaky, Mohamed Y.
    Liu, Xiuxiu
    Wang, Taishu
    Wang, Shanshan
    Liu, Fang
    Wang, Duchuang
    Wu, Yueguang
    Zhang, Yang
    Guo, Dong
    Sun, Qianhui
    Li, Qiong
    Zhang, Jinrui
    Zhang, Yingqiu
    Dong, Weijie
    Liu, Zhenhua
    Liu, Shuyan
    Liu, Han
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 680
  • [33] c-Met abnormatities in patients with genitourinary (GU) malignancies and outcomes with c-MET inhibitors.
    Jardim, Denis Leonardo Fontes
    Gagliato, Debora De Melo
    Falchook, Gerald Steven
    Wheler, Jennifer J.
    Zinner, Ralph
    Janku, Filip
    Subbiah, Vivek
    Piha-Paul, Sarina Anne
    Fu, Siqing
    Tannir, Nizar M.
    Corn, Paul Gettys
    Tang, Chad
    Hess, Kenneth R.
    Roy-Chowdhuri, Sinchita
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [34] CD82 regulation of c-Met in metastatic prostate cells.
    Sridhar, Suganthi
    Brandes, Emily
    Aller, Patrick
    Barrie, Eddie
    CANCER RESEARCH, 2021, 81 (13)
  • [35] c-Met is expressed by highly autoreactive encephalitogenic CD8+cells
    Benkhoucha, Mahdia
    Senoner, Isis
    Lalive, Patrice H.
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [36] c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
    Mahdia Benkhoucha
    Isis Senoner
    Patrice H. Lalive
    Journal of Neuroinflammation, 17
  • [37] Tumorpromotion in liver of conditional c-Met knockout mice
    Marx-Stoelting, P.
    Borowiak, M.
    Birchmeier, C.
    Buchmann, A.
    Schwarz, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 83 - 83
  • [38] MET (c-met, hepatocyte growth factor receptor)
    不详
    BULLETIN DU CANCER, 2005, 92 (09) : 751 - 752
  • [39] Heparan sulfate-modified CD44 promotes hepatocyte growth factor scatter factor induced signal transduction through the receptor tyrosine kinase c-Met
    van der Voort, R
    Taher, TEI
    Wielenga, VJM
    Spaargaren, M
    Prevo, R
    Smit, L
    David, G
    Hartmann, G
    Gherardi, E
    Pals, ST
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6499 - 6506
  • [40] 肝细胞肝癌组织c-Met、Fascin及CD44表达与临床病理特征及预后的相关性
    朱琳
    陈莉
    肖锋
    张海燕
    顾春燕
    中国临床医学, 2022, 29 (05) : 745 - 752